Ultrafast dynamic contrast-enhanced breast MRI with quantitative perfusion parameters in differentiating breast cancer: a study focusing on triple-negative and HER2 positive breast cancer

BackgroundIn the realm of breast cancer diagnosis and treatment, accurately discerning molecular subtypes is of paramount importance, especially when aiming to avoid invasive tests. The updated guidelines for diagnosing and treating HER2 positive advanced breast cancer, as presented at the 2021 Nati...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Guo Haodong, Zhu Jianguo, Dmytro Pylypenko, Dou Weiqiang, Su Sheng, Xu Jie, Li Haige
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Frontiers Media S.A. 2025-01-01
Ráidu:	Frontiers in Oncology
Fáttát:	differential subsampling with cartesian ordering contrast-enhanced MRI HER2 positive breast cancer triple-negative breast cancer kep HER2
Liŋkkat:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1457918/full
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!